A Multicenter, Randomized, Double-blind, Parallel Group Study to Determine the Optimal Dose of HL301 After 7 Days Oral Administration in Acute Bronchitis or Acute Exacerbations of Chronic Bronchitis Patients (HL301: Mixed Extract of Rehmannia Glutinosa, Schisandra and so on)

NCT02250027 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

156

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Bronchitis
Acute Exacerbations of Chronic Bronchitis

Interventions

DRUG: HL301 300mg capsule
DRUG: Placebo

Sponsor

Hanlim Pharm. Co., Ltd.